Get the Stockscreener App
5.44
6.46%
0.33
After Hours:
5.41
-0.03
-0.55%
Precision Biosciences Inc stock is traded at $5.44, with a volume of 90,196.
It is up +6.46% in the last 24 hours and down -34.38% over the past month.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
See More
Previous Close:
$5.11
Open:
$5.19
24h Volume:
90,196
Relative Volume:
0.60
Market Cap:
$72.12M
Revenue:
$52.29M
Net Income/Loss:
$-73.52M
P/E Ratio:
-8.2424
EPS:
-0.66
Net Cash Flow:
$-100.45M
1W Performance:
+8.80%
1M Performance:
-34.38%
6M Performance:
+9.46%
1Y Performance:
-23.49%
1-Day Range:
$5.1101
$5.44
1-Week Range:
$4.8601
$5.44
52-Week Range:
$3.61
$8.82
Precision Biosciences Inc Stock (DTIL) Company Profile
Name
Precision Biosciences Inc
Sector
Industry
Phone
919-314-5512
Address
302 EAST PETTIGREW STREET, DURHAM, NC
Compare DTIL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DTIL
Precision Biosciences Inc
|
5.44 | 123.01M | 52.29M | -73.52M | -100.45M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.61 | 109.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.19 | 82.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.23 | 58.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
911.98 | 56.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.77 | 43.62B | 447.02M | -1.18B | -906.14M | -6.1812 |
Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Apr-30-24 | Initiated | Guggenheim | Buy |
| Jun-17-22 | Initiated | BMO Capital Markets | Outperform |
| Jun-09-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-27-20 | Resumed | BTIG Research | Buy |
| Apr-03-20 | Downgrade | Goldman | Buy → Neutral |
| Mar-05-20 | Initiated | Stifel | Buy |
| Feb-25-20 | Initiated | William Blair | Outperform |
| Aug-09-19 | Initiated | BTIG Research | Buy |
| Jul-16-19 | Initiated | H.C. Wainwright | Buy |
| Apr-22-19 | Initiated | Barclays | Overweight |
| Apr-22-19 | Initiated | Goldman | Buy |
| Apr-22-19 | Initiated | JP Morgan | Overweight |
| Apr-22-19 | Initiated | Jefferies | Buy |
View All
Precision Biosciences Inc Stock (DTIL) Latest News
How Precision BioSciences Inc. stock compares to industry benchmarksJuly 2025 Levels & Daily Momentum Trading Reports - moha.gov.vn
Will Precision BioSciences Inc. stock outperform Nasdaq indexJuly 2025 Technicals & Free Weekly Chart Analysis and Trade Guides - moha.gov.vn
United StatesMintz Advises On Precision BioSciences, Inc.’s $75 Million Registered Direct Offering - Mondaq
H.C. Wainwright Keeps Their Buy Rating on Precision BioSciences (DTIL) - The Globe and Mail
Will Precision BioSciences Inc. stock return to pre crisis levelsLayoff News & Growth Focused Stock Reports - newser.com
Detecting price anomalies in Precision BioSciences Inc. with AIFed Meeting & Technical Confirmation Alerts - newser.com
How analysts rate Precision BioSciences Inc. stock todayMarket Sentiment Report & High Accuracy Swing Entry Alerts - newser.com
Will Precision BioSciences Inc. stock outperform Dow Jones indexAnalyst Downgrade & Weekly Top Gainers Alerts - newser.com
Will Precision BioSciences Inc. (PBS0) stock beat revenue estimates2025 Valuation Update & Safe Capital Growth Stock Tips - newser.com
Mintz Advises on Precision BioSciences, Inc.’s $75 Million Registered Direct Offering - Mintz
Precision BioSciences (DTIL) Price Target Decreased by 10.55% to 33.15 - MSN
How Precision BioSciences Inc. (PBS0) stock compares with market leaders2025 Momentum Check & Daily Stock Trend Reports - newser.com
Is Precision BioSciences Inc. stock dividend yield sustainableWeekly Risk Summary & Real-Time Chart Pattern Alerts - newser.com
Is Precision BioSciences Inc. (PBS0) stock a contrarian opportunity2025 Buyback Activity & Verified Short-Term Trading Plans - newser.com
Precision BioSciences Inc. (DTIL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why pension funds invest in Precision BioSciences Inc. (PBS0) stock2025 Retail Activity & High Return Stock Watch Alerts - newser.com
Precision BioSciences (Nasdaq: DTIL) to Present PBGENE-HBV Trial Data at Hep-DART 2025 - Stock Titan
Precision BioSciences Announces Presentation of Clinical Data from the ELIMINATE-B Trial at HEP-DART 2025 - Business Wire
Is Precision BioSciences Inc. (PBS0) stock in buy zone after pullback - newser.com
Genome Editing Market Research Report 2025-2032Industry - openPR.com
How hedge fund analytics apply to Precision BioSciences Inc. stock2025 Big Picture & Scalable Portfolio Growth Ideas - newser.com
Multi asset correlation models including Precision BioSciences Inc.July 2025 Market Mood & High Accuracy Trade Signal Alerts - newser.com
Can Precision BioSciences Inc. stock resist market sell offsJuly 2025 Opening Moves & Intraday High Probability Alerts - newser.com
Is Precision BioSciences Inc. stock positioned well for digital economy2025 Pullback Review & Weekly Market Pulse Alerts - newser.com
Real time breakdown of Precision BioSciences Inc. stock performanceIndex Update & Accurate Entry/Exit Alerts - newser.com
Has Precision BioSciences Inc. found a price floorPortfolio Value Report & Reliable Price Breakout Alerts - newser.com
Precision Biosciences Inc Stock (DTIL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
1.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):